Roche Sees Diagnostics Unit Growing Amid Health-Care Cost Cuts

Roche Holding AG expects government austerity measures to boost its medical-diagnostics unit in the next three to five years thanks to broader use of tests to see which patients should use expensive treatments.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.